{"id":877928,"date":"2025-08-21T11:11:31","date_gmt":"2025-08-21T15:11:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/"},"modified":"2025-08-21T11:11:31","modified_gmt":"2025-08-21T15:11:31","slug":"shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/","title":{"rendered":"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights &#8211; ANRO"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Aug. 21, 2025<\/span><\/span> \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of <b>Alto Neuroscience, Inc. (NYSE: ANRO).<\/b><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" title=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" alt=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p class=\"prntac\">CONTACT US HERE:<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492354-10&amp;h=428579967&amp;u=https%3A%2F%2Fsecuritiesclasslaw.com%2Fsecurities%2Falto-neuroscience-inc-loss-submission-form%2F%3Fid%3D162496%26from%3D4&amp;a=https%3A%2F%2Fsecuritiesclasslaw.com%2Fsecurities%2Falto-neuroscience-inc-loss-submission-form%2F%3Fid%3D162496%26from%3D4\" target=\"_blank\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=162496&amp;from=4<\/a>\n      <\/p>\n<p>\n        <b>CLASS PERIOD: <\/b>This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company&#8217;s initial public offering conducted on or about <span class=\"xn-chron\">February 2, 2024<\/span>; and\/or (b) Alto securities between <span class=\"xn-chron\">February 2, 2024<\/span> and <span class=\"xn-chron\">October 22, 2024<\/span>, both dates inclusive.<\/p>\n<p>\n        <b>ALLEGATIONS: <\/b>The complaint <span>alleges<\/span> that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) The Company&#8217;s product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe; (ii) accordingly, ALTO-100&#8217;s clinical, regulatory, and commercial prospects were overstated; (iii) as a result, Alto&#8217;s business and\/or financial prospects were overstated; and (iv) as a result, the Company&#8217;s public statements were materially false and misleading at all relevant times.<\/p>\n<p>\n        <b>DEADLINE: <span class=\"xn-chron\">September 19, 2025<\/span><\/b> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492354-10&amp;h=428579967&amp;u=https%3A%2F%2Fsecuritiesclasslaw.com%2Fsecurities%2Falto-neuroscience-inc-loss-submission-form%2F%3Fid%3D162496%26from%3D4&amp;a=https%3A%2F%2Fsecuritiesclasslaw.com%2Fsecurities%2Falto-neuroscience-inc-loss-submission-form%2F%3Fid%3D162496%26from%3D4\" target=\"_blank\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=162496&amp;from=4<\/a><\/p>\n<p>\n        <b>NEXT STEPS FOR SHAREHOLDERS: <\/b>Once you register as a shareholder who purchased shares of ANRO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is <span class=\"xn-chron\">September 19, 2025<\/span>. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <b>WHY GROSS LAW FIRM? <\/b>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, <span>fraud<\/span>, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/><span class=\"xn-location\">New York, NY<\/span>, 10018<br \/>Email: <a href=\"mailto:dg@securitiesclasslaw.com\" target=\"_blank\" rel=\"nofollow\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY55635&amp;sd=2025-08-21\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights--anro-302534877.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights&#8211;anro-302534877.html<\/a><\/p>\n<p>SOURCE  The Gross Law Firm<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY55635&amp;Transmission_Id=202508210845PR_NEWS_USPR_____NY55635&amp;DateId=20250821\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Aug. 21, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=162496&amp;from=4 CLASS PERIOD: This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company&#8217;s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights &#8211; ANRO&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-877928","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights - ANRO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights - ANRO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Aug. 21, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=162496&amp;from=4 CLASS PERIOD: This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company&#8217;s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 &hellip; Continue reading &quot;Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights &#8211; ANRO&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-21T15:11:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights &#8211; ANRO\",\"datePublished\":\"2025-08-21T15:11:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/\"},\"wordCount\":463,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/\",\"name\":\"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights - ANRO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"datePublished\":\"2025-08-21T15:11:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights &#8211; ANRO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights - ANRO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/","og_locale":"en_US","og_type":"article","og_title":"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights - ANRO - Market Newsdesk","og_description":"PR Newswire NEW YORK , Aug. 21, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=162496&amp;from=4 CLASS PERIOD: This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company&#8217;s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 &hellip; Continue reading \"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights &#8211; ANRO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-21T15:11:31+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights &#8211; ANRO","datePublished":"2025-08-21T15:11:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/"},"wordCount":463,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/","name":"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights - ANRO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","datePublished":"2025-08-21T15:11:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-alto-neuroscience-inc-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights &#8211; ANRO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=877928"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877928\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=877928"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=877928"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=877928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}